Other Helicobacters and gastric microbiota

Helicobacter

Volumn 21, Issue , 2016, Pages 62-68

  De Witte, Chloë ^a   Schulz, Christian ^b   Smet, Annemieke ^a   Malfertheiner, Peter ^b   Haesebrouck, Freddy ^a  

^a GHENT UNIVERSITY   (Belgium)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

enterohepatic Helicobacter; gastric microbiota; gastric non Helicobacter pylori Helicobacter

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; BINDING PROTEIN; NICKEL BINDING PROTEIN; OUTER MEMBRANE PROTEIN; PHOSPHOLIPASE C GAMMA2; PROTEIN BAK; UNCLASSIFIED DRUG; UREB PROTEIN;

BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; DISEASE SEVERITY; HELICOBACTER; HELICOBACTER CINAEDI; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH THROUGHPUT SEQUENCING; HUMAN; INFECTION PREVENTION; INTESTINE FLORA; NON HELICOBACTER PYLORI INFECTION; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 84982130906     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12343     Document Type: Review

References (76)

1. Flahou B, Haesebrouck F, Pasmans F, et al. Helicobacter suis causes severe gastric pathology in mouse and mongolian gerbil models of human gastric disease. PLoS One. 2010;5:e14083.
2. Kobayashi M, Yamamoto K, Ogiwara N, Matsumoto T, Shigeto S, Ota H. Helicobacter heilmannii-like organism in parietal cells: a diagnostic pitfall. Pathol Int. 2016;66:120–122.
3. Goji S, Tamura Y, Sasaki M, et al. Helicobacter suis-infected nodular gastritis and a review of diagnostic sensitivity for Helicobacter heilmannii-like organisms. Case Rep Gastroenterol. 2015;9:179–187.
4. Kiss S, Zsikla V, Frank A, Willi N, Cathomas G. Helicobacter-negative gastritis: polymerase chain reaction for Helicobacter DNA is a valuable tool to elucidate the diagnosis. Aliment Pharmacol Ther. 2016;43:924–932.
5. Esmail MY, Bacon R, Swennes AG, et al. Helicobacter species identified in Captive Sooty Mangabeys (Cercocebus atys) with metastatic gastric adenocarcinoma. Helicobacter. 2016;21:175–185.
6. Menard A, Buissonniere A, Prouzet-Mauleon V, Sifre E, Megraud F. The GyrA encoded gene: a pertinent marker for the phylogenetic revision of Helicobacter genus. Syst Appl Microbiol. 2016;39:77–87.
7. Joosten M, Linden S, Rossi M, et al. Divergence between the highly virulent Zoonotic pathogen Helicobacter heilmannii and its closest relative, the low-virulence “Helicobacter ailurogastricus” sp. nov. Infect Immun. 2015;84:293–306.
8. Dong HJ, Ho H, Hwang H, et al. Diversity of the gastric microbiota in Thoroughbred racehorses having gastric ulcer. J Microbiol Biotechnol. 2016;26:763–774.
9. Mori N, Kagawa N, Higuchi A, Aoki Y, Ohkusu K. Sepsis dto a novel urease-positive Helicobacter species in a young man. J Clin Microbiol. 2015;53:2378–2380.
10. Anderson ME, O'Brien EC, Grayek EN, Hermansen JK, Hunt HK. The detection of Helicobacter hepaticus using whispering-gallery mode microcavity optical sensors. Biosensors (Basel). 2015;5:562–576.
11. Hong S, Chung Y, Kang WG, Choi YS, Kim O. Comparison of three diagnostic assays for the identification of Helicobacter spp. in laboratory dogs. Lab Anim Res. 2015;31:86–92.
12. Shen Z, Feng Y, Sheh A, et al. Isolation and characterization of a novel Helicobacter species, Helicobacter jaachi sp. nov., from common marmosets (Callithrix jaachus). J Med Microbiol. 2015;64:1063–1073.
13. Pritchett-Corning KR, Peery HE, Crossland JP, Wyatt HM, Stuart M, Mothersill CE. Use of neonatal fostering to remove Helicobacter spp. from deer mice (Peromyscus maniculatus). J Am Assoc Lab Anim Sci. 2015;54:439–444.
14. Pritchett-Corning KR, Gaskill BN. Lack of negative effects on Syrian hamsters and Mongolian gerbils housed in the same secondary enclosure. J Am Assoc Lab Anim Sci. 2015;54:261–266.
15. Yamanaka H, Nakanishi T, Takagi T, et al. Helicobacter sp. MIT 01-6451 infection during fetal and neonatal life in laboratory mice. Exp Anim. 2015;64:375–382.
16. Stasilojc M, Hinc K, Peszynska-Sularz G, Obuchowski M, Iwanicki A. Recombinant Bacillus subtilis spores elicit Th1/Th17-polarized immune response in a murine model of Helicobacter pylori vaccination. Mol Biotechnol. 2015;57:685–691.
17. Ding H, Nedrud JG, Blanchard TG, et al. Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization. PLoS One. 2013;8:e69384.
18. Velin D, Favre L, Bernasconi E, et al. Interleukin-17 Is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology. 2009;136:2237–2246.
19. Moyat M, Mack M, Bouzourene H, Velin D. Role of inflammatory monocytes in vaccine-induced reduction of Helicobacter felis infection. Infect Immun. 2015;83:4217–4228.
20. Harbour SN, Mitchell HM, Sutton P. Host nonresponsiveness does not interfere with vaccine-mediated protection against gastric Helicobacter infection. Helicobacter. 2015;20:217–222.
21. Bosschem I, Bayry J, De Bruyne E, et al. Effect of different adjuvants on protection and side-effects induced by Helicobacter suis whole-cell lysate vaccination. PLoS One. 2015;10:e0131364.
22. De Bruyne E, Ducatelle R, Foss D, et al. Oral glutathione supplementation drastically reduces Helicobacter-induced gastric pathologies. Sci Rep. 2016;6:20169.
23. Lee JY, Kim N, Choi YJ, et al. Anti-inflammatory and anti-tumorigenic effects of Acai Berry in Helicobacter felis-infected mice. J Cancer Prev. 2016;21:48–54.
24. Liu C, Rossi M, Linden S, Padra M, Blaecher C, Bauwens E, et al. The Helicobacter heilmannii hofE and hofF genes are essential for colonization of the gastric mucosa and play a Role in IL-1beta-induced gastric MUC13 expression. Helicobacter. 2016; doi: 10.1111/hel.12307.
25. Gossmann J, Stolte M, Lohoff M, et al. A Gain-of-function mutation in the Plcg2 gene protects mice from Helicobacter felis-induced gastric MALT lymphoma. PLoS One. 2016;11:e0150411.
26. Duckworth CA, Abuderman AA, Burkitt MD, Williams JM, O'Reilly LA, Pritchard DM. bak deletion stimulates gastric epithelial proliferation and enhances Helicobacter felis-induced gastric atrophy and dysplasia in mice. Am J Physiol Gastrointest Liver Physiol. 2015;309:G420–G430.
27. Vinella D, Fischer F, Vorontsov E, et al. Evolution of Helicobacter: acquisition by gastric species of two histidine-rich proteins essential for colonization. PLoS Pathog. 2015;11:e1005312.
28. Namburi RB, Berteau O, Spillmann D, Rossi M. Chondroitinase AC: a host-associated genetic feature of Helicobacter bizzozeronii. Vet Microbiol. 2016;186:21–27.
29. Cravedi P, Mori G, Fischer F, Percudani R. Evolution of the Selenoproteome in Helicobacter pylori and Epsilonproteobacteria. Genome Biol Evol. 2015;7:2692–2704.
30. Frank J, Dingemanse C, Schmitz AM, et al. The complete genome sequence of the murine pathobiont Helicobacter typhlonius. Front Microbiol. 2015;6:1549.
31. Pere-Vedrenne C, Cardinaud B, Varon C, et al. The Cytolethal Distending Toxin subunit CdtB of Helicobacter induces a Th17-related and antimicrobial signature in intestinal and hepatic cells in vitro. J Infect Dis. 2016;213:1979–1989.
32. Parente MR, Monteiro JT, Martins GG, Saraival LM. Helicobacter pullorum induces nitric oxide release in murine macrophages that promotes phagocytosis and killing. Microbiology. 2016;162:503–512.
33. Walugembe M, Hsieh JC, Koszewski NJ, Lamont SJ, Persia ME, Rothschild MF. Effects of dietary fiber on cecal short-chain fatty acid and cecal microbiota of broiler and laying-hen chicks. Poult Sci. 2015;94:2351–2359.
34. Borges V, Santos A, Correia CB, et al. Helicobacter pullorum isolated from fresh chicken meat: antibiotic resistance and genomic traits of an emerging foodborne pathogen. Appl Environ Microbiol. 2015;81:8155–8163.
35. Woods SE, Ek C, Shen Z, et al. Male Syrian hamsters experimentally infected with Helicobacter spp. of the H. bilis cluster develop MALT-associated gastrointestinal lymphomas. Helicobacter. 2016;21:201–217.
36. Dingemanse C, Belzer C, van Hijum SA, et al. Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. Carcinogenesis. 2015;36:1388–1396.
37. Arnold IC, Mathisen S, Schulthess J, Danne C, Hegazy AN, Powrie F. CD11c(+) monocyte/macrophages promote chronic Helicobacter hepaticus-induced intestinal inflammation through the production of IL-23. Mucosal Immunol. 2016;9:352–363.
38. Morrison PJ, Ballantyne SJ, Macdonald SJ, et al. Differential requirements for IL-17A and IL-22 in cecal versus colonic inflammation induced by Helicobacter hepaticus. Am J Pathol. 2015;185:3290–3303.
39. Zimmermann J, Kuhl AA, Weber M, et al. T-bet expression by Th cells promotes type 1 inflammation but is dispensable for colitis. Mucosal Immunol. 2016 Feb17. [Epub ahead of print].
40. Brasseit J, Althaus-Steiner E, Faderl M, et al. CD4 T cells are required for both development and maintenance of disease in a new mouse model of reversible colitis. Mucosal Immunol. 2016;9:689–701.
41. Ray A, Basu S, Gharaibeh RZ, et al. Gut Microbial dysbiosis due to Helicobacter drives an increase in marginal zone B cells in the absence of IL-10 signaling in macrophages. J Immunol. 2015;195:3071–3085.
42. Kamimura K, Kumaki D, Arita M, et al. First case of bacteremia caused by Helicobacter cinaedi in a patient with liver cirrhosis: a case report and literature review. Clin J Gastroenterol. 2015;8:306–317.
43. Miyake N, Chong Y, Nishida R, et al. A dramatic increase in the positive blood culture rates of Helicobacter cinaedi: the evidence of differential detection abilities between the Bactec and BacT/Alert systems. Diagn Microbiol Infect Dis. 2015;83:232–233.
44. Shimizu S, Shimizu H. A review of the cutaneous manifestations of Helicobacter cinaedi. J Dermatol. 2015 Dec18. [Epub ahead of print].
45. Imafuku A, Araoka H, Tanaka K, et al. Helicobacter cinaedi bacteremia in four renal transplant patients: clinical features and an important suggestion regarding the route of infection. Transpl Infect Dis. 2016;18:132–136.
46. Nielsen HL, Prag J, Krogfelt KA. Helicobacter cinaedi knee infection after arthroscopy in an immunocompetent patient. BMJ Case Rep. 2015 Oct6. [Epub ahead of print].
47. Mishima K, Obara H, Sugita K, et al. Helicobacter cinaedi bacteremia with cellulitis after ABO-incompatible living-donor liver transplantation: case report. World J Gastroenterol. 2015;21:7911–7915.
48. Toyofuku M, Tomida J, Kawamura Y, Miyata I, Yuza Y, Horikoshi Y. Helicobacter cinaedi bacteremia resulting from antimicrobial resistance acquired during treatment for X-linked agammaglobulinemia. J Infect Chemother. 2016 Mar31. [Epub ahead of print].
49. Maki Y, Furukawa S, Kodama Y, Sumiyoshi K, Kino E, Sameshima H. Preterm labor and neonatal sepsis caused by intrauterine Helicobacter cinaedi infection. J Infect. 2016;22:414–416.
50. Haruki Y, Hagiya H, Hashimoto T, et al. Pyogenic spondylitis and diskitis caused by Helicobacter cinaedi in an immunocompetent adult patient. Intern Med. 2015;54:2415–2418.
51. Adachi Y, Moriya C, Fujisawa T, et al. Recurrent superficial cellulitis-like erythema associated with Helicobacter cinaedi bacteremia. J Dermatol. 2016; 43:844–846.
52. Uwamino Y, Muranaka K, Hase R, Otsuka Y, Hosokawa N. Clinical features of community-acquired Helicobacter cinaedi bacteremia. Helicobacter. 2016;21:24–28.
53. Nishida K, Iwasawa T, Tamura A, Lefor AT. Infected abdominal aortic aneurysm with Helicobacter cinaedi. Case Rep Surg. 2016; 2016:627–632.
54. Unosawa S, Niino T. An infected abdominal aortic aneurysm caused by Helicobacter cinaedi. Ann Vasc Dis. 2015;8:318–320.
55. Yoshizaki A, Takegawa H, Doi A, Mizuno Y, Nishioka H. Vertebral osteomyelitis caused by Helicobacter cinaedi. J Clin Microbiol. 2015;53:3054–3056.
56. Murata S, Suzuki H, Sakamoto S, et al. Helicobacter cinaedi-associated vertebral osteomyelitis in an immunocompetent patient. Intern Med. 2015;54:3221–3224.
57. Akashi Y, Igarashi J, Suzuki H, et al. Pararenal lymphatic cyst infection caused by Helicobacter cinaedi. Intern Med. 2015;54:1437–1440.
58. Nakamura I, Ohkusu K, Nakagami Y, Tachibana M, Matsumoto T. First case report of bacteremia due to ‘Campylobacter-like organism 3′. Int J Infect Dis. 2016;42:51–53.
59. Taniguchi T, Yamazaki W, Saeki Y, et al. The pathogenic potential of Helicobacter cinaedi isolated from non-human sources: adherence, invasion and translocation ability in polarized intestinal epithelial Caco-2 cells in vitro. J Vet Med Sci. 2016; 78:627–632.
60. Patel K, Konduru K, Patra AK, Chandel DS, Panigrahi P. Trends and determinants of gastric bacterial colonization of preterm neonates in a NICU setting. PLoS One. 2015;10:e0114664.
61. Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther. 2001;15:379–388.
62. Freedberg DE, Lebwohl B, Abrams JA. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med. 2014;34:771–785.
63. Amir I, Konikoff FM, Oppenheim M, Gophna U, Half EE. Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors. Environ Microbiol. 2014;16:2905–2914.
64. Sung J, Kim N, Kim J, et al. Comparison of gastric microbiota between gastric juice and mucosa by Next Generation Sequencing method. J Cancer Prev. 2016;21:60–65.
65. Lertpiriyapong K, Whary MT, Muthupalani S, et al. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut. 2014;63:54–63.
66. Lofgren JL, Whary MT, Ge ZM, et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology. 2011;140:210–220.
67. Jo HJ, Kim J, Kim N, et al. Analysis of gastric microbiota by pyrosequencing: minor role of bacteria other than Helicobacter pylori in the gastric carcinogenesis. Helicobacter. 2016 Feb 24. [Epub ahead of print].
68. Wang L, Zhou J, Xin Y, et al. Bacterial overgrowth and diversification of microbiota in gastric cancer. Eur J Gastroenterol Hepatol. 2016;28:261–266.
69. Yang I, Woltemate S, Piazuelo MB, et al. Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia. Sci Rep. 2016;6:18594.
70. Probiotics in food. Health and Nutritional Properties and Guidelines for Evaluation Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food, Including Powder Milk With Live Lactic Acid Bacteria Cordoba, Argentina, 1–4 October 2001 Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, vol. 85. FAO food and nutrition paper, Rome: Food and Agriculture Organization of the United Nations; 2006.
71. Pan M, Wan C, Xie Q, et al. Changes in gastric microbiota induced by Helicobacter pylori infection and preventive effects of Lactobacillus plantarum ZDY 2013 against such infection. J Dairy Sci. 2016;99:970–981.
72. Oh B, Kim JW, Kim BS. Changes in the functional potential of the gut microbiome following probiotic supplementation during Helicobacter pylori treatment. Helicobacter. 2016 Mar18. [Epub ahead of print].
73. Aiba Y, Nakano Y, Koga Y, Takahashi K, Komatsu Y. A highly acid-resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin-mediated acid production in mice. Microbiologyopen. 2015;4:465–474.
74. Kienesberger S, Cox LM, Livanos A, et al. Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Rep. 2016;14:1395–1407.
75. Khosravi Y, Seow SW, Amoyo AA, et al. Helicobacter pylori infection can affect energy modulating hormones and body weight in germ free mice. Sci Rep. 2014 Mar4. [Epub ahead of print].
76. Khosravi Y, Bunte RM, Chiow KH, et al. Helicobacter pylori and gut microbiota modulate energy homeostasis prior to inducing histopathological changes in mice. Gut Microbes. 2016;7:48–53.